Koru Medical Systems Inc (KRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 02-2011 | 02-2010 | 02-2009 | 12-2008 | 02-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 704 | 889 | 1,031 | N/A | -3 |
| Depreciation Amortization | 66 | 65 | 79 | 60 | 68 |
| Income taxes - deferred | 487 | N/A | -306 | N/A | N/A |
| Accounts receivable | -59 | -166 | -192 | N/A | -83 |
| Accounts payable and accrued liabilities | 77 | -139 | -123 | N/A | -41 |
| Other Working Capital | -226 | -577 | -295 | -300 | -86 |
| Other Operating Activity | -22 | 311 | 334 | 20 | 262 |
| Operating Cash Flow | $1,029 | $382 | $528 | $-220 | $118 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -152 | N/A | N/A | N/A | N/A |
| PPE Investments | -201 | -52 | -63 | -10 | -39 |
| Purchase Sale Intangibles | -1 | -4 | -1 | N/A | -8 |
| Other Investing Activity | -1 | -4 | -1 | 0 | -8 |
| Investing Cash Flow | $-353 | $-56 | $-64 | $-10 | $-46 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 8 | 379 | N/A | 420 |
| Debt Repayment | -166 | -40 | -419 | N/A | -487 |
| Dividend Paid | N/A | N/A | N/A | 0 | -8 |
| Other Financing Activity | 0 | 0 | 0 | -30 | 0 |
| Financing Cash Flow | $-166 | $-32 | $-41 | $-30 | $-75 |
| Beginning Cash Position | 813 | 519 | 96 | N/A | 99 |
| End Cash Position | 1,322 | 813 | 519 | N/A | 96 |
| Net Cash Flow | $509 | $294 | $424 | $-260 | $-4 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,029 | 382 | 528 | -220 | 118 |
| Capital Expenditure | -201 | -52 | -63 | N/A | -39 |
| Free Cash Flow | 828 | 330 | 465 | -220 | 79 |